Iron chelation with oral deferiprone in patients with thalassemia (multiple letters) [1]

New England Journal of Medicine

Volumn 339, Issue 23, 1998, Pages 1710-1714

  Tricta, F ^a   Spino, M ^a   Callea, F ^a   Nathan, D G ^a   Weatherall, D J ^a   Stella, M ^a   Pinzello, G ^a   Maggio, A ^a   Wonke, B ^a   Telfer, P ^a   Hoffbrand, A V ^a   Grady, R W ^a   Giardina, P J ^a   Cohen, A R ^a   Martin, M B ^a   Brittenham, G M ^a   Fleming, K A ^a   Templeton, D M ^a   Olivieri, N F ^a   Kowdley, K V ^a   Kaplan, M M ^a   more..

^a Apotex Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; FERRITIN; HEPATITIS C ANTIBODY; IRON; PYRIDONE DERIVATIVE; VIRUS RNA; IRON CHELATING AGENT;

BLOOD TRANSFUSION; HEPATITIS C; HUMAN; IRON CHELATION; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; THALASSEMIA; BETA THALASSEMIA; BIOPSY; IRON OVERLOAD; LIVER; METHODOLOGY; NOTE; PATHOLOGY;

BETA-THALASSEMIA; BIOPSY; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; LIVER CIRRHOSIS; PYRIDONES;

EID: 0032481094     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812033392313     Document Type: Letter

References (0)